Abiopharma

🔍 Craig Jonathan M. (Executive)

Company: SCHWAB CHARLES CORP (SCHW)

Report Date: 2026-08-05

Detailed Transactions and Holdings:

• Acquired 21,750 shares of Common Stock at $46.81 per share (Direct)
  Date: 2026-08-05 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 21,750 shares of Common Stock at $107.0231 per share (Direct)
  Date: 2026-08-05 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F1
• Sold 21,750 shares of Nonqualified Stock Option (right to buy) at $46.81 per share (Derivative)
  Date: 2026-08-05 | Code: M | Expires: 2029-03-01 | equity_swap_involved: 0 | shares_owned_after: 21,866.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Reflects the contribution of the shares received upon exercise of the option to a revocable trust.
• F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025.
• F3: The transaction was executed in multiple trades at prices ranging from $107.005 to $107.06. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the transfer of shares and prices at which the transaction was effected.
• F4: The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.